myirislogo
15 November, 2019 21:05 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 322.00 5.19
Cipla . 463.10 2.57
Bharti Artl 393.20 8.42
Power Grid 187.40 0.32
Tata Motors 168.60 0.96
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Sterling Biotech Limited
Sterling Biotech Limited
Sector:Chemicals Chemicals - Chemicals - Others
BSE:12299NSE:STERLINBIOBloomberg:SLT@INReuters:STBI.BO
Market Lot: 1Face Value: 1ISIN Demat: INE324C01038
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
07-AUG-10 Sterling Biotech has posted a net profit of Rs 447.04 million for the quarter ended Jun. 30, 2010 as compared to Rs 404.74 million for the same quarter a year ago, rise of 10.45%. Future Plans The company plans to borrow funds by way of secured/collateral loans, bonds, securities or other instruments having an aggregate value of about Rs. 15 billion to finance the assets as well as working capital requirements from time to time. ...   More..
Business Profile Future Plans
One To One
Face To Face
Sterling Biotech Ltd, the largest manufacturer of gelatin has undertaken expansion of Rs 236 crores. The gelatin demand in domestic market to grow by 15 per cent while globally the growth to be around 3 per cent.  Nitin Sandesara,Chairman
Recent news
Previous

 


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)30-Jun-2016(6)31-Dec-2015(12)31-Dec-2014 (12)
Net sales 2170.534120.566669.51
Other Income0.000.000.00
Total Income2170.534120.566669.51
Cost of goods sold2572.605008.545557.13
OPBDIT-402.07-887.981112.38
PAT-1793.85-3768.49-4577.05
Gross Block---
Equity capital272.17272.05272.05
EPS (Rs.)---16.82
DPS (Rs.)---
BV (Rs.)---
P/E range (x)--NA
Debt / Equity (x)---
Operating margin (% of OI)-18.5-21.516.7
Net margin (% of OI)-82.6-91.5-68.6
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
43, Atlanta
Nariman Point
Mumbai
Maharashtra-400 021
PHONE
(022) 6630 6732 / 33
FAX
(022) 2204 1954
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer